Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Wanbangde Pharmaceutical Holding Group Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Wanbangde Pharmaceutical Holding Group has a total shareholder equity of CN¥2.8B and total debt of CN¥932.3M, which brings its debt-to-equity ratio to 33.4%. Its total assets and total liabilities are CN¥4.3B and CN¥1.5B respectively. Wanbangde Pharmaceutical Holding Group's EBIT is CN¥43.9M making its interest coverage ratio 1.1. It has cash and short-term investments of CN¥153.5M.
Anahtar bilgiler
33.4%
Borç/özkaynak oranı
CN¥932.32m
Borç
| Faiz karşılama oranı | 1.1x |
| Nakit | CN¥153.50m |
| Eşitlik | CN¥2.79b |
| Toplam yükümlülükler | CN¥1.53b |
| Toplam varlıklar | CN¥4.32b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002082's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥1.3B).
Uzun Vadeli Yükümlülükler: 002082's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥184.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002082's net debt to equity ratio (27.9%) is considered satisfactory.
Borcun Azaltılması: 002082's debt to equity ratio has reduced from 45% to 33.4% over the past 5 years.
Borç Kapsamı: 002082's debt is well covered by operating cash flow (20.6%).
Faiz Kapsamı: 002082's interest payments on its debt are not well covered by EBIT (1.1x coverage).